Arbutus Biopharma Corporation
ABUS
$4.58
$0.173.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.51% | -25.40% | -26.68% | -30.92% | -12.79% |
| Total Receivables | 12,957.38% | -35.51% | -36.84% | -45.57% | -49.54% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -51.01% | -37.60% | -17.56% | -6.26% | -30.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 137.15% | -25.81% | -26.61% | -30.43% | -14.03% |
|
|
|||||
| Total Current Assets | 137.15% | -25.81% | -26.61% | -30.43% | -14.03% |
| Net Property, Plant & Equipment | -86.90% | -99.27% | -97.09% | -97.21% | -97.07% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 285.29% | 282.35% | -- | -- | -- |
| Total Assets | 136.87% | -28.16% | -30.43% | -35.48% | -22.14% |
|
|
|||||
| Total Accounts Payable | -34.73% | -49.35% | -56.33% | -50.19% | -40.15% |
| Total Accrued Expenses | -29.12% | -30.53% | -38.27% | -71.39% | -13.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.08% | 13.25% | 13.46% | 13.47% | 12.15% |
| Total Finance Division Other Current Liabilities | -98.07% | -91.55% | -93.35% | -93.04% | 10.19% |
| Total Other Current Liabilities | -98.07% | -91.55% | -93.35% | -93.04% | 10.19% |
| Total Current Liabilities | -73.73% | -61.54% | -72.60% | -77.77% | -4.26% |
|
|
|||||
| Total Current Liabilities | -73.73% | -61.54% | -72.60% | -77.77% | -4.26% |
| Long-Term Debt | -25.65% | -28.72% | -30.69% | -33.27% | -31.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -75.31% | -60.02% | -49.74% | -46.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -35.73% | -35.86% | 32.60% | 34.95% | 72.07% |
| Total Liabilities | -55.12% | -47.46% | -39.46% | -46.02% | 6.17% |
|
|
|||||
| Common Stock & APIC | 1.36% | 0.85% | 0.86% | 0.99% | 2.81% |
| Retained Earnings | 11.72% | -2.49% | -3.17% | -4.13% | -5.91% |
| Treasury Stock & Other | -0.06% | 0.08% | -0.08% | 0.25% | 0.42% |
| Total Common Equity | 228.68% | -21.35% | -27.59% | -32.24% | -30.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 228.68% | -21.35% | -27.59% | -32.24% | -30.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 228.68% | -21.35% | -27.59% | -32.24% | -30.95% |
|
|
|||||